BABiniyam Alemayehu Ayele

Biniyam Alemayehu Ayele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Biniyam Alemayehu Ayele has a total of 204 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of Clinical Guideline Use in the Prevention, Diagnosis, and Treatment of Cryptococcal Meningitis Among Health Care Providers in Ethiopia

    by Blen M Gebresilassie, Gerome B Vallejos, Ryan S Walker, Omosefe Noruwa, Kathryn B Holroyd, Temesgen Nurye, Carla Kim, Biniyam Ayele, Kiran T Thakur

    Background: Cryptococcal meningitis (CM) is a significant cause of morbidity and mortality in individuals with advanced HIV. Ethiopia, with a high HIV burden and significant socioeconomic challenges, has limited data on CM. Understanding clinical practices is crucial to identifying gaps and improving disease management. Methods: A survey was conducted among health care workers (HCWs), microbiologists, and pharmacists across 9 Ethiopian health facilities from July to November 2024. Eligibility required active involvement in HIV or CM care. Ethics approval and informed consent were secured. Three profession-specific questionnaires were used to assess knowledge of CM care and challenges. Data were analyzed in R, version 4.3.2. Results: A total of 311 participants were included: HCWs, n = 202; microbiologists, n = 65; and pharmacists, n = 44. Most participants, 188/202 (93.1%) HCWs, 42/44 (95.5%) pharmacists, and 54/65 (83.1%) microbiologists, recognized the need for additional guideline training. Only 59/202 (29%) HCWs reported that screening for cryptococcal antigenemia was always performed. Among antifungals, fluconazole was the most available, with 21/44 (48%) pharmacists and 49/202 (24%) HCWs reporting it as always in stock. Liposomal amphotericin B (L-Amb) was reported as available by only 7/44 (16%) pharmacists and 44/202 (22%) HCWs. The most significant barriers to guideline implementation were insufficient policy support and challenges in integrating guidelines into electronic health records, as reported by 152/202 (75.2%) and 143/202 (70.8%) HCWs, respectively. Conclusions: There are substantial gaps in CM care, highlighting the importance of improving resource allocation, technical assistance, additional training, and financial support.


  • Research capacity and capability development for dementia research in majority-world settings

    by Biniyam A. Ayele, Rachel Fitzpatrick, Bernard Fongang, Iracema Leroi, Geeske Peeters

    This chapter examines the Nairobi Declaration on Reducing the Burden of Dementia in Low- and Middle-Income Countries (LMICs), which calls for ‘research into affordable, effective solutions to improve dementia care while reducing hospitalization costs and mitigating brain drain by engaging young professionals.’ Although cognitive and neurodegenerative disorders are increasingly recognized as public health priorities in LMICs, local research in these regions is still developing. Local research is essential for addressing the complexities of dementia care within specific contexts, amid a severe shortage of health professionals prepared for this research. This chapter covers three key aspects of capacity and capability development: (1) setting research agendas and prioritizing questions across countries; (2) enhancing African scientists’ expertise and access to research data through the AI-BOND initiative; and (3) best practices for equitable international collaborations in dementia research.

  • Open Access

    Early Metabolic Alterations in Cerebrospinal Fluid Fatty Acid Profiles Linked to Cognitive Decline and All-Cause Dementia

    by Jacob Apibilla Ayembilla, Yannick N. Wadop, Rebecca Bernal, Biniyam A. Ayele, Murali Sargurupremraj, Xueqiu Jian, Alfred K. Njamnshi, Sudha Seshadri, Alice B. S. Nono Djotsa, Jayandra Jung Himali, et al.

    Background: While All-cause dementia (ACD) may often be characterized by the abnormal deposition of extracellular β-amyloid (Aβ) in the brain cortex and hyperphosphorylated tau (p-tau) as neurofibrillary tangles intracellularly, there is a need to identify early metabolic changes that may accompany these pathological changes. Objective: This study evaluated the predictive value of fatty acids in cerebrospinal fluid (CSF) fractions in differentiating cognitively unimpaired (CU), mild cognitive impairment (MCI), and ACD participants. Methods: CSF fatty acid profiles were analyzed from CU (n=68), MCI (n=38), and ACD (n=37) individuals aged 77.3 ± 7.7 years, sourced from the Huntington Medical Research Institutes (HMRI). Multivariable binary logistic regression identified the most effective CSF fatty acid biomarkers for distinguishing CU, MCI, and ACD groups. The top-performing CSF fatty acid biomarkers were combined with Aβ 42 , tau, and the Aβ 42 /tau ratio to evaluate their collective diagnostic performance. The model was adjusted for covariates, including age, sex, smoking status, hypertension, diabetes, and APOE genotype. Receiver operating characteristic (ROC) curves were generated for the top 10 CSF fatty acids ranked by area under the curve (AUC), sensitivity, and specificity, and their significance was assessed using the DeLong test. Results: The top 10 fatty acids in CSF fractions demonstrated superior discrimination between CU individuals and those with MCI compared to traditional markers such as Aβ 42 , tau, and the Aβ 42 /tau ratio. Furthermore, incorporating a panel of these fatty acid biomarkers alongside Aβ 42 /tau significantly improved diagnostic accuracy. Age, sex, smoking, hypertension, APOE genotype, and diabetes did not significantly influence the model’s performance. Conclusion: This study suggests that changes in fatty acid metabolism occur in early ACD pathology. Thus, strategies that regulate fatty acid metabolism may prevent cognitive decline in an older population. Highlights: This study revealed that CSF fractions’ fatty acids have a better discriminatory power for CU from MCI than CSF Aβ 42 , tau, and Aβ 42 /tau ratio. A panel of CSF fraction fatty acids combined with Aβ 42 /tau remarkably improved its diagnostic performance for differential diagnosis of CU, MCI, and ACD. Clinical evaluation of these fatty acids will strengthen the detection of early cognitive impairment. A prospective large cohort multicenter study of the diagnostic utility of CSF fractions’ fatty acids will provide robust evidence before extensive clinical usage of these fatty acids.

  • Open Access

    Statin-induced Myonecrosis—A Rare Adverse Effect of a Common Drug: A Case Report

    by Hanna Demissie, Kemal Ali, Dagnaw Mersha, Salhadin Mohammed, Winny Costa Mapour, Biruktawit Michael, Desalegn Yayeh, Biniyam A. Ayele

    Background: Clinically significant statin-induced myonecrosis is a rare clinical disorder that affects the skeletal muscles of patients taking statin medication. Its clinical presentation ranges from mild muscle pain to muscle weakness associated with significant elevation (>10×) of serum creatinine kinase (CK). Early screening, identification, and treatment of statin-induced myopathy are vital as it may lead to drug discontinuation and poor medication adherence. Case Report: We report a 40-year-old male diabetic patient who visited our neurology referral clinic with a two-week history of muscle pain associated with proximal extremities’ weakness, which later progressed to involve the distal extremity muscles of his upper and lower limbs. A week before his presentation to our hospital, he became wheelchair-bound. Six months before his admission, he was started on a daily dose of 40 mg oral simvastatin for prevention, given his cardiovascular risk factors. No history of fever, headaches, abnormal body movement; no personal or family history of similar illness; no history of trauma, alcohol use, smoking, or use of herbal medication was elicited. His CK levels were elevated 19 times, and electromyography examination showed a myopathic pattern in proximal muscles. Following the discontinuation of simvastatin, the patient’s muscle weakness significantly improved. In addition, his serum CK levels also lowered significantly on his follow-up evaluation. Conclusion: This case describes a diabetic patient with statin-induced myonecrosis, managed conservatively through statin withdrawal. It also highlights the benign prognosis in younger patients, showing that the condition generally has a favorable outcome with timely diagnosis and management.

  • Meningiomatosis Restricted to the Left Cerebral Hemisphere Presenting with Frontal Lobe Seizure: A Short Communication

    by Biniyam A. Ayele, Hilina Dagnachew, Meskerem Nimani, Jarsso Tadesse Hirbu

    Seizures are a common clinical feature of benign intracranial brain tumors such as meningioma. Although seizures are cortical phenomena that typically originate from lesions affecting cortical neurons, meningiomas, which arise from the meningeal lining, can still induce seizures due to their proximity to the cerebral cortex. However, the relationship between multiple meningiomas and frontal lobe seizures remains underexplored. We present the case of a 42-year-old woman without neurofibromatosis who experienced global headaches and nocturnal motor seizure involving the right hemi body, associated with loss of consciousness. The motor fits frequently occur at night. Brain magnetic resonance image (MRI) and electroencephalograph (EEG) show multiple meningioma and left frontal epileptogenic focus, respectively. The patient was managed conservatively with anticonvulsant.

  • Open Access

    Plasma biomarkers are stable for an extended period at –20°C: Implications for resource‐constrained environments

    by Biniyam A. Ayele, Patrice L. Whitehead, Tianjie Gu, Jamie Arvizu, Charles G. Golightly, Larry D. Adams, Margaret A Pericak‐Vance, Jeffery M. Vance, Anthony J. Griswold

    Background: The Recruitment and Retention for Alzheimer’s Disease Diversity Cohorts in the Alzheimer’s Disease Sequencing Project (REAAD‐ADSP) aims to explore ADRD in diverse ancestral groups within the US and nine countries from sub‐Saharan Africa. While most laboratories store plasma samples ‐80°C for biomarkers, no studies at –20°C have been reported past 2 weeks. Only two sites in Africa possess ‐80°C freezers. As biomarkers can be frozen and thawed, we hypothesized they would be stable at –20°C. The present study was designed to investigate the stability of AD plasma biomarkers at –20°C over time to facilitate studies of plasma biomarkers in resource‐constrained regions.Methods: Peripheral blood was collected from six anonymous volunteers. Plasma was isolated via centrifugation and 200mL aliquots of plasma were made. Two aliquots per participant were stored immediately at ‐80°C and others at ‐20°C for two, four, six and fifteen weeks then moved to ‐80°C. Plasma biomarkers, pTau181 and Aβ42, Aβ40, NFL, and GFAP, were measured for each time point. Each aliquot was run in duplicate in the assay plate and two aliquots per participant per time point were assayed.Results: There was a range values at baseline for each biomarker across the six participants: pTau181: 1.6‐3.0pg/mL, Aβ42: 3.7‐6.3pg/mL, Aβ40: 56.2‐106.6pg/mL, NFL: 3.5‐14.9pg/mL, GFAP: 42.9‐71.1pg/mL. At week fifteen, the average change in pTau181 was 0.14pg/mL, less than a 10% overall change. The Aβ42/40 ratio showed a decrease of 3.6% in week 15 compared to the baseline. Variability in NFL and GFAP were higher with increases in all subjects in week 15. Such run variance has been noted for these biomarkers by the manufacturer, thus our results suggest that after fifteen weeks at ‐20°C the assays are performing within specifications.Conclusion: Up to 15 weeks of storage of plasma at ‐20°C does not significantly change AD related plasma biomarker concentrations beyond assay specifications, though there are slight increases in GFAP and NFL. This suggests that locations lacking ‐80°C storage can utilize ‐20°C equipment and still maintain biomarker fidelity, allowing for greater representation of biomarker studies from low‐ and middle‐ income countries, increasing the diversity of studies in AD.

  • Open Access

    AD plasma biomarkers are stable for an extended period at –20°C: implications for resource-constrained environments

    by Biniyam A. Ayele, Patrice L. Whitehead, Julianna Pascual, Tianjie Gu, Jamie Arvizu, Charles G. Golightly, Larry D. Adams, Margaret A. Pericak-Vance, Jeffery M. Vance, Anthony J. Griswold

    Standard procedures for measuring Alzheimer’s disease (AD) plasma biomarkers include storage at -80°C. This is challenging in countries lacking research infrastructure, such -80°C freezer. To investigate stability of AD biomarkers from plasma stored at -20°C, we compared aliquots stored at -80°C and others at -20°C for two, four, six, fifteen, and thirty-five weeks. pTau181, Aβ42, Aβ40, NfL, and GFAP were measured for each timepoint. pTau181 and Aβ42/Aβ40 ratios showed minimal variation for up to 15 weeks. NfL and GFAP had higher variability. This finding of 15-week stability at -20°C enables greater participation in AD biomarker studies in resource constrained environments.

  • Association between cognitive impairment and antiseizure medication adherence among people with epilepsy in Addis Ababa, Ethiopia

    by Blen Mamo, Anteneh M. Feyissa, Tariku Mengesha, Biniyam A. Ayele, Yared Mamushet Yifru


  • Open Access

    Role of Neuroimaging in Suspected Dementia Patients: Utilization of Structural Imaging Algorithmic‐Based Diagnosis in Resource Limited Settings

    by Biniyam A. Ayele

    Background: In 2050, it is estimated that the number of dementia patients in the sub Saharan Africa is expected to reach 5.05 million, an increase of 136% from the previous estimate of 2.14 million. The objectives of the present study were to assess the neuroimaging findings and associated factors in dementia suspected patients.Method: A retrospective survey of the medical records of 121 suspected dementia patients whom presented to the Yehuleshet Specialty Clinic with subjective forgetfulness were reviewed. The study duration was between January 1, 2020 and December 31, 2021. Both descriptive and analytical statistics were used to analyze the data.Result: The mean age was 70.4 (1SD = 10.3) years. Sixty four (52.9%) participants were age below 70. Male accounted for 57.9%. Hyperlipidemia was the commonest (38%) identified vascular risk factor followed by prevalence of hypertension (32.2%) and diabetes mellitus (22.3%). HIV infection was observed in 3.3%. Low mean serum vitamin D level (below 20ng/mL) was observed in individuals with focal & global cortical atrophy and those with white matter hyperintensity. Fifty two (43%) participants fulfilled the clinical and imaging criteria of vascular cognitive impairment (VCI). Nearly quarter of the patients had imaging evidences of focal or global cortical atrophy. Eleven (9.1%) had imaging evidences of surgical causes of dementia. the presences of comorbid hypertension, previous stroke, and Parkinsonism were independent predictors of vascular dementia.Conclusion: The present study shows high burden of vascular cognitive impairment among individuals suspected of dementia.Furthermore, the presences of comorbid hypertension, previous stroke, and Parkinsonism were independent predictors of vascular dementia.

  • Open Access

    The need for a tailored National Dementia Plan in Ethiopia: a call for action

    by Biniyam A. Ayele

    Background: Globally, a rapid demographic transition is occurring with a significant increment in the proportion of older individuals. For the first time in history, individuals aged 65 and above outnumber that of children under five years of age.Method: A mini review was conducted to assess the burden and types of dementia risk factors in Ethiopia.Results: In Ethiopia, the life expectancy has shown dramatic improvements in the past few decades and is expected to reach 74 years by mid‐century. Older age is considered the most important non‐modifiable risk factor for dementia. Likewise, other modifiable diseases such as infectious diseases, non‐communicable diseases, particularly cardiovascular diseases, and traumatic brain injuries are associated with dementia. Despite, the high prevalence of dementia risk factors and impending economic and health impact from dementia, no country in the sub‐Saharan Africa (SSA), including Ethiopia, has developed a standalone national dementia strategic plan to guide the overall effort to improve dementia care in the country. It is vital to design and develop a national dementia plan in line with a framework outlined by the 2017 World Health Organization (WHO) global action plan. The health, social, & economic burden from dementia is expected to be high to the developing countries such as Ethiopia unless clear prevention and management strategies are designed at a national level to cascade the care to the primary care level. The planned strategic policy may focus on improving the knowledge and skills of health care professionals. Translation and cultural adaptation of cognitive, functional, and behavioral assessment batteries is of paramount importance in improving the diagnostic accuracy along with availability of advanced imaging, biomarkers, and dementia treatment.Conclusion: In summary, this call for action paper recommends developing a tailored stand‐alone or an integrated national dementia prevention and care plan which is in congruent with the seven WHO global action plan.